Advancing Cancer Care with Bispecific Therapies: Clinical Insights & Community Implementation
This conference offers cutting-edge insights into emerging therapies for solid tumors and hematologic malignancies. Leading experts will present clinical advances, practical use of bispecifics, toxicity management, and CNS complications. This program is designed to provide oncologists, advanced practice providers, nurses, and pharmacists with evidence-based guidance to support community implementation of a bispecific program.
Breakfast and registration open on Saturday at 7:00 a.m. The conference will conclude at 3:15 p.m.
We welcome non-industry attendees to join us Friday evening from 6:30 to 8:30 p.m., for a sponsored dinner and networking program in the Ballantyne Carolina Room.
